02186 LUYE PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.24X | Oper Margin | 23.1% |
|---|---|---|---|
| LT Debt/Equity | 19.3% | Net Margin | 7.8% |
| Total Debt/Equity | 72.9% | Return on Equity | 3.3% |
| Price/Book | 0.91X | Return on Assets | 1.6% |
| (HKD 3.650) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 501.85 | 587.04 | 678.11 | -164.37 | 838.58 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -14.5 | -13.4 | +512.5 | -119.6 | -46.3 |
| Earnings Per Share (HKD) | 0.133 | 0.158 | 0.195 | -0.048 | 0.263 |
| Earnings Per Share Growth (%) | -15.3 | -19.2 | +508.4 | -118.1 | -46.0 |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 27.36 | 23.17 | 18.74 | N/A | 13.87 |
| Yield (%) | N/A | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 4.002 | 3.672 | 3.214 | 2.932 | 2.883 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 6,061 | 6,143 | -1.3 | 5,982 |
| Operating Result | 821.505 | 697.806 | +17.7 | 668.931 |
| Associates | -0.774 | 0.794 | -197.5 | 0.831 |
| Profit Before Taxation | 839.219 | 700.1 | +19.9 | 669.762 |
| Taxation | 194.211 | 161.023 | +20.6 | 86.466 |
| Profit /( Loss) After Taxation | 645.008 | 539.077 | +19.7 | 583.296 |
| Minority Interests | 173.122 | 6.472 | +2,574.9 | -21.511 |
| Net Profit | 471.886 | 532.605 | -11.4 | 604.807 |
| Earnings Per Share () | 0.1334 | 0.1575 | -15.3 | 0.1948 |
| Announcement Date | 2025-03-30 | 2024-03-27 | NA | 2023-03-29 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
